XML 51 R34.htm IDEA: XBRL DOCUMENT v3.25.4
SHARE-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation Costs by Plan The following table summarizes the components of the Company’s employee and non-employee directors share-based compensation programs recognized as selling and administrative expense:
SuccessorPredecessor
Year ended December 31,Period from 08/12/2023 through 12/31/2023Period from 01/01/2023 through 08/11/2023
20252024
Pre-tax compensation expense$3.4 $4.1 $0.1 $— 
Tax benefit(0.7)(0.9)— — 
Stock option expense, net of tax(1)
$2.7 $3.2 $0.1 $— 
Pre-tax compensation expense$8.7 $5.6 $— $2.3 
Acceleration of Predecessor awards— — — 2.7 
Tax benefit(1.5)(1.3)— (1.2)
RSU expense, net of tax(2)
$7.2 $4.3 $— $3.8 
Pre-tax compensation expense$— $— $— $0.1 
Performance share expense, net of tax$— $— $— $0.1 
Pre-tax compensation expense$12.1 $9.7 $0.1 $2.4 
Acceleration of Predecessor awards— — — 2.7 
Tax benefit(2.2)(2.2)— (1.2)
Total share-based compensation, net of tax$9.9 $7.5 $0.1 $3.9 
(1) Unrecognized compensation costs related to unvested stock option awards as of December 31, 2025 was $6.1, which will be amortized over a weighted average period of 1.7 years.
(2) Unrecognized compensation costs related to unvested RSU awards as of December 31, 2025 was $14.3, which will be amortized over a weighted average period of 1.4 years.
Schedule of Weighted Average Grant Date Fair Value for Stock Option and RSU The table below summarizes the weighted average grant date fair value for stock option and RSU awards:
SuccessorPredecessor
Year ended December 31,Period from 08/12/2023 through 12/31/2023Period from 01/01/2023 through 08/11/2023
20252024
Stock options$— $12.41 $4.73 $— 
RSUs$44.53 $34.66 $29.00 $— 
Schedule of Stock Options Outstanding and Exercisable Stock option and RSU awards outstanding and exercisable as of December 31, 2025, and changes during the period were as follows:
Stock optionsRSUs
Number of SharesWeighted-Average Exercise Price (per share)Weighted-Average Remaining Contractual Term (in years)Aggregate Intrinsic ValueNumber of SharesWeighted-Average Exercise Price (per share)Weighted-Average Remaining Contractual Term (in years)Aggregate Intrinsic Value
Outstanding at January 1, 20251.1 $31.58 0.6 $32.60 
Expired or forfeited(0.1)$30.00 (0.1)$33.22 
Exercised— $— (0.2)$33.21 
Granted— $— 0.2 $44.53 
Outstanding at December 31, 20251.0 $31.73 5.5$— 0.5 $37.66 
Exercisable at December 31, 20250.3 $30.00 2.7$— N/AN/AN/AN/A